Advisor Group’s Pfizer PFE Stock Holding History

Advisor Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Buy	+254	New	+$9.05K	﹤0.01%	4464

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisor Group's PFE Position: Q4 2019 in Review

Advisor Group increased its Pfizer (PFE) stake by 0.92% in Q4 2019, buying an estimated $238K and bringing the position to 733,280 shares worth $27.3M. The position accounts for 0.19% of the portfolio, ranked #99.

Advisor Group first reported a position in PFE in Q2 2016 and has held it in 15 quarters since. The position peaked at $27.9M in Q2 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

Advisor Group held 733,280 shares of Pfizer worth $27.3M as of Q4 2019.
Advisor Group bought 6,672 Pfizer shares in Q4 2019, an estimated $238K.
Pfizer made up 0.19% of Advisor Group's portfolio in Q4 2019, its #99 holding.
Advisor Group first reported a position in Pfizer in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Pfizer position peaked at $27.9M in Q2 2019.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.